ExomeDNA exists to bring meaningful health information closer to the people it belongs to.

TThis started at a funeral. My wife's cousin — a young mother — died quickly of MS. She didn't see it coming. I uploaded my wife's raw DNA to Promethease and fed the output into a conversation with an AI, and I learned what I wouldn't have learned from a static report: that specific lifestyle interventions, in her case centered on vitamin B, could meaningfully reduce risk. One conversation changed what we do every day.

Expand that conversation to every risk, every protective variant, every well-studied trait. That's the product. Not a report. A conversation with your own genes, grounded in peer-reviewed study associations, that you can return to as long as the science keeps growing.

This isn't about profit. It's about preventing bad outcomes that were preventable. If one person reads their report and catches something early — or avoids something entirely because they made different choices — the company justified itself.